Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6PEMIGATINIB

02 3Pemigatinib

03 3Ponatinib

04 1RETIFANLIMAB-DLWR

05 6RUXOLITINIB PHOSPHATE

06 1TAFASITAMAB

07 1Tafasitamabum

08 1axatilimab-csfr

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : NIKTIMVO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NIKTIMVO

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : INJECTABLE;INTRAVENOUS

Brand Name : NIKTIMVO

Dosage Strength : 50 MG/ML

Packaging :

Approval Date :

Application Number : 761411

Regulatory Info :

Registration Country : USA

blank

02

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET;ORAL

Brand Name : PEMAZYRE

Dosage Strength : 4.5MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET;ORAL

Brand Name : PEMAZYRE

Dosage Strength : 9MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET;ORAL

Brand Name : PEMAZYRE

Dosage Strength : 13.5MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : Pemazyre

2024 ACI Convention
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : Tabl

Brand Name : Pemazyre

Dosage Strength : 13.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Brand Name : Pemazyre

2024 ACI Convention
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : Tabl

Brand Name : Pemazyre

Dosage Strength : 4.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Brand Name : Pemazyre

2024 ACI Convention
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : Tabl

Brand Name : Pemazyre

Dosage Strength : 9mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET

Brand Name : PEMAZYRE

Dosage Strength : 4.5MG

Packaging :

Approval Date :

Application Number : 2519933

Regulatory Info : Prescription

Registration Country : Canada

blank

09

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET

Brand Name : PEMAZYRE

Dosage Strength : 9MG

Packaging :

Approval Date :

Application Number : 2519941

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET

Brand Name : PEMAZYRE

Dosage Strength : 13.5MG

Packaging :

Approval Date :

Application Number : 2519968

Regulatory Info : Prescription

Registration Country : Canada

blank